An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

HEXTEND (6% Hetastarch in Lactated Electrolyte Injection)

NDA Number: BN200952
Manufacturer: Hospira, Inc.
Product name: HEXTEND (6% Hydroxyethyl Starch in Lactated Electrolyte Injection)
Indication:

Treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. It is not a substitute for blood or plasma.

Product Information

Package Insert - HEXTEND (6% Hetastarch in Lactated Electrolyte Injection)

Supporting Documents

Top